Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 807-814

  Gross, Johann ^a   Fuchs, Julia ^a   Machulik, Astrid ^a   Jahnke, Volker ^a   Kietzmann, Thomas ^b   Bockmühl, Ulrike ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c KLINIKUM FULDA   (Germany)

Author keywords

Apoptosis; Head and neck squamous cell carcinoma; HIF 1 ; Necrosis

Indexed keywords

ACETYLCYSTEINE; COBALT; COBALT CHLORIDE; DEFEROXAMINE; DNA BINDING PROTEIN; DRUG DERIVATIVE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTACYSTIN; MESSENGER RNA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL NUCLEUS; CELL SHAPE; COMPARATIVE STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NECROSIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE;

ACETYLCYSTEINE; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL NUCLEUS; CELL SHAPE; COBALT; DEFEROXAMINE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NECROSIS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 24344481339     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hockel M and Vaupel P: Tumor Hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001.
2. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS and Coomber BL: Heterogeneous vascular dependence of tumor cell populations. Am I Pathol 158: 1325-1334, 2001.
3. Brizel DM, Sibley GS, Prosnitz LR, Seller RL and Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-289, 1997.
4. Nordsmark M, Overgaard M and Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39, 1996.
5. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH and Semenza GL: Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61: 2911-2916,2001.
6. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91,1996.
7. Harris AL: Hypoxia-a key regulatory factor in tumour growth. Nature Rev Cancer 2: 38-47, 2002.
8. Seta KA and Millhorn DE: Functional genomics approach to hypoxia signaling. J Appl Physiol 96: 765-773, 2004.
9. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM and Johnson RS: Hypoxia-inducible factor-1 alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015, 2000.
10. Bardos JI and Ashcroft M: Hypoxia-inducible factor-1 and oncogenic signalling. Bioessays 26: 262-269, 2004.
11. Hara S, Hamada J, Kobayashi C, Kondo Y and Imura N: Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun 287:808-813,2001.
12. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Gatter KC and Harris AL: Hypoxiainducible factor (HIF1A and HIF2A), angiogenesis and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53: 1192-1202, 2002.
13. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S and Harris AL: Hypoxia-inducible factors HIF-1 alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62: 2493-2497, 2002.
14. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Holland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R and Begg AC: HIF-1 A, pimonidazole and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 54: 1537-1549, 2002.
15. Wang GL and Semenza GL: Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
16. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
17. Hòckel M, Schlenger K, Hockel S and Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59: 4525-4528, 1999.
18. D'Amico AV and McKenna WG: Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother Oncol 33: 3-10, 1994.
19. Gross J, Rheinlander C, Fuchs J, Mazurek B, Machulik A, Andreeva N and Kietzmann T: Expression of hypoxia-inducible factor-1 in the cochlea of newborn rats. Hear Res 183: 73-83, 2003.
20. Gross J, Muller I, Berndt CH, Ungethum U, Heldt J, Elizalde M, Peters LE and Andersson K: Quantitation of dopamine D2 receptor mRNA in a mesencephalic cell culture using nonradioactive reverse transcription polymerase chain reaction method. J Neurose Method 82: 187-194, 1998.
21. Weber U and Gross HJ: In vitro RNAs. In: Antisense Technology. Lichtenstein C and Nellen W (eds). Oxford University Press, Oxford, New York, Tokyo, pp75-91, 1997.
22. Kietzmann T, Cornesse Y, Brechtel K, Modaressi S and Jungermann K: Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIFlalpha, HIF2alpha and HIF3alpha, in rat liver. Biochem J 354: 531-537, 2001.
23. Charlier N, Leclere N, Felderhoff U, Heldt J, Kietzmann T, Obladen M and Gross J: Hypoxia-induced cell death and changes in hypoxia-inducible factor-1 activity in PC12 cells upon exposure to nerve growth factor. Brain Res Mol Brain Res 104: 21-30,2002.
24. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ and Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54,2001.
25. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M and Esumi H: Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001.
26. Semenza GL: Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207-214, 1998.
27. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M and Remade J: Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29: E21, 2001.
28. Kaufman CK, Sinha S, Bolotin D, Fan J and Fuchs E: Dissection of a complex enhancer element: maintenance of keratinocyte specificity but loss of differentiation specificity. Mol Cell Biol 22: 4293-4308, 2002.
29. Mastyugin V, Mezentsev A, Zhang WX, Ashkar S, Dunn MW and Laniado-Schwartzman M: Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia. J Cell Biochem 91: 1218-1238,2004.
30. Boast K, Binley K, Iqball S, Price T, Spearman H, Kingsman S, Kingsman A and Naylor S: Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum Gene Ther 10: 2197-2208, 1999.
31. Chou SC, Azuma Y, Varia MA and Raleigh J A: Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. Br J Cancer 90: 728-735, 2004.
32. Mahon PC, Hirota K and Semenza GL: FIH-1: a novel protein that interacts with HIF-1 alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686, 2001.
33. Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG and Wenger RH: Heat induction of the unphosphorylated form of hypoxia-inducible factor-1 alpha is dependent on heat shock protein-90 activity. J Biol Chem 277: 9262-9267, 2002.
34. Piret JP, Mottet D, Raes M and Michiels C: Is HIF-1 alpha a proor an anti-apoptotic protein? Biochem Pharmacol 64: 889-892, 2002.
35. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Coilen D and Keshet E: Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.
36. Halterman MW, Miller CC and Federoff HJ: Hypoxia-inducible factor-1 alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 19: 6818-6824, 1999.
37. Sheridan MT, West CM, Cooper RA, Stratford IJ, Logue JP, Davidson SE and Hunter RD: Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy. Br J Cancer 82: 1177-1182,2000.
38. Cuisnier O, Serduc R, Lavieille JP, Longuet M, Reyt E and Riva C: Chronic hypoxia protects against gamma-irradiationinduced apoptosis by inducing bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein. Int J Oncol 23: 1033-1041, 2003.
39. Riedel F, Gotte K, Bergler W and Hormann K: Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol Rep 8: 471-476, 2001.
40. Polischouk AG, Grenman R, Granath F and Lewensohn R: Radiosensitivity of human squamous carcinoma cell lines is associated with amount of spontaneous DNA strand breaks. Int J Cancer 96 (Suppl): S43-S53,2001.
41. Donner KJ, Becker KM, Hissong BD and Ahmed SA: Comparison of multiple assays for kinetic detection of apoptosis in thymocytes exposed to dexamethasone or diethylstilbesterol. Cytometry 35: 80-90, 1999.